To include your compound in the COVID-19 Resource Center, submit it here.

Sequenom's target practice

Through its genome screening technology, Sequenom Inc. has generated targets in 11 disease areas. Like many target companies, SQNM now has determined that it has more targets than capacity. Thus, SQNM believes that its first full disease area

Read the full 382 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers